Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Hutter

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
Leukemia|March 14, 2021
Correction: complex landscape of alternative splicing in myeloid neoplasmsCourtney E Hershberger, Devlin C Moyer, Vera Adema, et al.
Leukemia|August 6, 2020
Complex landscape of alternative splicing in myeloid neoplasmsCourtney E Hershberger, Devlin C Moyer, Vera Adema, et al.
Nature Communications|February 25, 2022
Circulating microbial content in myeloid malignancy patients is associated with disease subtypes and patient outcomesJakob Woerner, Yidi Huang, Stephan Hutter, et al.
Genome Medicine|May 20, 2024
Analysis of 3760 hematologic malignancies reveals rare transcriptomic aberrations of driver genesXueqi Cao, Sandra Huber, Ata Jadid Ahari, et al.
Hemasphere|April 20, 2026
IntegrateALL: An end-to-end RNA-seq analysis pipeline for multilevel data extraction and interpretable subtype classification in B-precursor ALLNadine Wolgast, Thomas Beder, Mayukh Mondal, et al.
Ebiomedicine|May 26, 2022
Pathophysiologic and clinical implications of molecular profiles resultant from deletion 5qVera Adema, Laura Palomo, Wencke Walter, et al.
Leukemia|June 27, 2022
Rare germline alterations of myeloperoxidase predispose to myeloid neoplasmsSunisa Kongkiatkamon, Laila Terkawi, Yihong Guan, et al.
Blood|September 22, 2025
Telomere content and genomics of myeloid neoplasia by whole-genome sequencingLuca Guarnera, Adam Wahida, Carmelo Gurnari, et al.
Blood Advances|September 30, 2021
A geno-clinical decision model for the diagnosis of myelodysplastic syndromesNathan Radakovich, Manja Meggendorfer, Luca Malcovati, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2021
Personalized Prediction Model to Risk Stratify Patients With Myelodysplastic SyndromesAziz Nazha, Rami Komrokji, Manja Meggendorfer, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Leukemia|March 14, 2021
Correction: complex landscape of alternative splicing in myeloid neoplasmsCourtney E Hershberger, Devlin C Moyer, Vera Adema, et al.
Leukemia|August 6, 2020
Complex landscape of alternative splicing in myeloid neoplasmsCourtney E Hershberger, Devlin C Moyer, Vera Adema, et al.
Nature Communications|February 25, 2022
Circulating microbial content in myeloid malignancy patients is associated with disease subtypes and patient outcomesJakob Woerner, Yidi Huang, Stephan Hutter, et al.
Genome Medicine|May 20, 2024
Analysis of 3760 hematologic malignancies reveals rare transcriptomic aberrations of driver genesXueqi Cao, Sandra Huber, Ata Jadid Ahari, et al.
Hemasphere|April 20, 2026
IntegrateALL: An end-to-end RNA-seq analysis pipeline for multilevel data extraction and interpretable subtype classification in B-precursor ALLNadine Wolgast, Thomas Beder, Mayukh Mondal, et al.
Ebiomedicine|May 26, 2022
Pathophysiologic and clinical implications of molecular profiles resultant from deletion 5qVera Adema, Laura Palomo, Wencke Walter, et al.
Leukemia|June 27, 2022
Rare germline alterations of myeloperoxidase predispose to myeloid neoplasmsSunisa Kongkiatkamon, Laila Terkawi, Yihong Guan, et al.
Blood|September 22, 2025
Telomere content and genomics of myeloid neoplasia by whole-genome sequencingLuca Guarnera, Adam Wahida, Carmelo Gurnari, et al.
Blood Advances|September 30, 2021
A geno-clinical decision model for the diagnosis of myelodysplastic syndromesNathan Radakovich, Manja Meggendorfer, Luca Malcovati, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2021
Personalized Prediction Model to Risk Stratify Patients With Myelodysplastic SyndromesAziz Nazha, Rami Komrokji, Manja Meggendorfer, et al.
Pageof 8